238 related articles for article (PubMed ID: 29808066)
1. Management of prediabetes.
Priya G
J Pak Med Assoc; 2018 Apr; 68(4):669-671. PubMed ID: 29808066
[TBL] [Abstract][Full Text] [Related]
2. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
[TBL] [Abstract][Full Text] [Related]
3. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
[TBL] [Abstract][Full Text] [Related]
4. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
[No Abstract] [Full Text] [Related]
5. Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes.
Bennasar-Veny M; Fresneda S; López-González A; Busquets-Cortés C; Aguiló A; Yañez AM
Nutrients; 2020 May; 12(5):. PubMed ID: 32466178
[TBL] [Abstract][Full Text] [Related]
6. Effect of intensive lifestyle modification & metformin on cardiovascular risk in prediabetes: A pilot randomized control trial.
Kulkarni S; Xavier D; George B; Umesh S; Fathima S; Bantwal G
Indian J Med Res; 2018 Dec; 148(6):705-712. PubMed ID: 30778004
[TBL] [Abstract][Full Text] [Related]
7. Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial.
Li X; Liu H; Feng H; Xian Z; Chen Y; Chen J; Tang C; Lai X; Lan X; Huang H; Yu D
Trials; 2017 Jun; 18(1):297. PubMed ID: 28659162
[TBL] [Abstract][Full Text] [Related]
8. Prediabetes: a high-risk state for diabetes development.
Tabák AG; Herder C; Rathmann W; Brunner EJ; Kivimäki M
Lancet; 2012 Jun; 379(9833):2279-90. PubMed ID: 22683128
[TBL] [Abstract][Full Text] [Related]
9. Risk of progression to diabetes from prediabetes defined by HbA1c or fasting plasma glucose criteria in Koreans.
Kim CH; Kim HK; Kim EH; Bae SJ; Choe J; Park JY
Diabetes Res Clin Pract; 2016 Aug; 118():105-11. PubMed ID: 27368062
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Management of Prediabetes: A Review.
Echouffo-Tcheugui JB; Perreault L; Ji L; Dagogo-Jack S
JAMA; 2023 Apr; 329(14):1206-1216. PubMed ID: 37039787
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic risk profile of participants with prediabetes diagnosed by HbA1c criteria in an urban Hong Kong Chinese population over 40 years of age.
Woo YC; Cheung BM; Yeung CY; Lee CH; Hui EY; Fong CH; Tso AW; Tam S; Lam KS
Diabet Med; 2015 Sep; 32(9):1207-11. PubMed ID: 25594838
[TBL] [Abstract][Full Text] [Related]
12. Assessment of clinical and biochemical profile of prediabetic subject in Bangladesh, attending in BIRDEM and results of intervention by lifestyle modification, metformin, and DPP4 inhibitor.
Barua M; Pathan F; Nabi MU; Kabir M
Diabetes Metab Syndr; 2019; 13(2):1603-1608. PubMed ID: 31336528
[TBL] [Abstract][Full Text] [Related]
13. Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype.
Campbell MD; Sathish T; Zimmet PZ; Thankappan KR; Oldenburg B; Owens DR; Shaw JE; Tapp RJ
Nat Rev Endocrinol; 2020 Jul; 16(7):395-400. PubMed ID: 32060416
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes.
Luo Y; Wang H; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Paul SK
J Diabetes Res; 2022; 2022():2971382. PubMed ID: 35036447
[TBL] [Abstract][Full Text] [Related]
15. Reflecting on type 2 diabetes prevention: more questions than answers!
Rosenstock J
Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
[TBL] [Abstract][Full Text] [Related]
16. Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany.
Greiner GG; Emmert-Fees KMF; Becker J; Rathmann W; Thorand B; Peters A; Quante AS; Schwettmann L; Laxy M
Acta Diabetol; 2020 Dec; 57(12):1481-1491. PubMed ID: 32748175
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke.
Matz K; Tuomilehto J; Teuschl Y; Dachenhausen A; Brainin M
Cardiovasc Diabetol; 2020 Dec; 19(1):204. PubMed ID: 33278898
[TBL] [Abstract][Full Text] [Related]
18. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
Fonseca VA
Clin Cornerstone; 2007; 8(2):10-8; discussion 19-20. PubMed ID: 18357952
[TBL] [Abstract][Full Text] [Related]
19. Approach to the patient with prediabetes.
Aroda VR; Ratner R
J Clin Endocrinol Metab; 2008 Sep; 93(9):3259-65. PubMed ID: 18772457
[TBL] [Abstract][Full Text] [Related]
20. Treatment recommendations for prediabetes.
Ratner RE; Sathasivam A
Med Clin North Am; 2011 Mar; 95(2):385-95, viii-ix. PubMed ID: 21281840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
